ImageneBio, Inc.
IMA· Nasdaq
Released Nov 10, 2021, before the open
10-Q filed Nov 10, 2021, 41 days after period end · 0000950170-21-003871
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2021 | Q3 2020 |
|---|---|---|
| Revenue | $3.75M | $2.83M |
| Net Income | -$14.52M | -$6.22M |
| EPS Diluted | -$0.40 | -$2.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ImageneBio, Inc. · CIK 1835579 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 10, 2021 · 41 d after period end